CanSino Biologics Inc.
Clinical trials sponsored by CanSino Biologics Inc., explained in plain language.
A vaccine company developing and manufacturing vaccines, including for COVID-19.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a Freeze-Dried vaccine shield all ages from hib? Results expected Oct 2026 (estimated)
- Could a Virus-Like particle vaccine outsmart polio? Results expected Oct 2026 (estimated)
- Tetanus immunity under the microscope: do antibodies hold up after 2.5 years? Results expected Nov 2026 (estimated)
- New 24-Strain pneumonia vaccine enters human trials Results expected Nov 2026 (estimated)
- New vaccine aims to shield infants from deadly pneumonia Results expected Feb 2027 (estimated) 🚀 Make-or-break
-
Tetanus immunity under the microscope: do antibodies hold up after 2.5 years?
Knowledge-focused Not yet recruitingThis study checks how long protection from a tetanus vaccine lasts. Researchers take blood samples from 240 people who received the vaccine or a control in an earlier trial, 2.5 years after their shots. They measure antibody levels to see if they still meet protective thresholds.…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Vaccine Follow-Up: how long does protection last in babies?
Knowledge-focused Not yet recruitingThis study follows 100 infants who received a pneumococcal vaccine in an earlier trial. Researchers will take a small blood sample to measure antibody levels one and two years after vaccination. The goal is to see how long protection against pneumococcal infections lasts. No new …
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Will a single DTP vaccine dose protect for a decade? study tracks antibodies
Knowledge-focused Not yet recruitingThis study follows 160 people who previously received a 5-component DTP vaccine (protecting against diphtheria, tetanus, and pertussis) to see how long their immune protection lasts. Blood samples are taken at 2.5, 5, and 10 years after vaccination to measure antibody levels. The…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could a single meningitis shot protect for years? a study investigates
Knowledge-focused Not yet recruitingThis study follows 180 children who received a meningitis vaccine (ACYW135 conjugate) years ago to see if their immune protection lasts. Researchers will measure antibody levels in blood samples taken 3 and 5 years after vaccination. The goal is to understand how long immunity pe…
Sponsor: CanSino Biologics Inc. • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC